1,228 patents currently held
368 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
19 more records may belong here and await a decision; they are not counted.
The next term ends in Nov 2026. from the record
Of the 368 now held by other companies, 107 name Udc Ireland Limited as their current owner, and 261 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
124
Ending by 2030
Nov 2026
Next term end
1,067
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2035 · High confidence
Also notable
Ends May 2033 · High confidence
Also notable
Ends Dec 2036 · High confidence
Also notable
Ends Jan 2032 · High confidence
Also notable
Ends Aug 2037 · High confidence
Also notable
Ends Feb 2035 · High confidence
Also notable
Ends Apr 2037 · High confidence
Also notable
Ends Nov 2034 · High confidence
Materials for Organic Light Emitting Devices
US 10,622,565
Cited by 62 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2035.
ANTI-PD-L1 Antibodies and Uses Thereof
US 9,624,298
Cited by 46 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
TLR7/8 Antagonists and Uses Thereof
US 10,399,957
Cited by 23 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2036.
Engineered heterodimeric protein domains
US 8,871,912
Cited by 56 later US patents, top 10% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2032.
TLR7/8 Antagonists and Uses Thereof
US 10,947,214
Cited by 17 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2037.
Targeted Tgf¿ Inhibitor
US 9,676,863
Cited by 34 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Materials for Organic Electroluminescent Devices
US 11,608,327
Cited by 4 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2037.
Heterocyclic Spiro Compounds
US 10,777,750
Cited by 18 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2034.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 7 fees due Nov 21 to 28, 2026 · next Nov 21
- 11 fees due Dec 2 to 25, 2026 · next Dec 2
- 25 fees due Jan 2 to 30, 2027 · next Jan 2
- 33 fees due Feb 1 to 28, 2027 · next Feb 1
- 26 fees due Mar 1 to 29, 2027 · next Mar 1
- 37 fees due Apr 1 to 30, 2027 · next Apr 1
- 19 fees due May 3 to 28, 2027 · next May 3
- 22 fees due Jun 1 to 30, 2027 · next Jun 1
- 32 fees due Jul 2 to 30, 2027 · next Jul 2
- 21 fees due Aug 2 to 27, 2027 · next Aug 2
- 26 fees due Sep 1 to 30, 2027 · next Sep 1
- 27 fees due Oct 2 to 30, 2027 · next Oct 2
- 13 fees due Nov 3 to 19, 2027 · next Nov 3
Recent changes
- Nov 18Assignment recorded on 1 record: EMD Millipore Corporation to Merck Patent GmbH Recorded Nov 18, 2026, executed May 12, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76808, frame 419.
- Nov 18Assignment recorded on 1 record: Merck Life Science KGaA to Merck Patent GmbH Recorded Nov 18, 2026, executed Nov 3, 2025. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76808, frame 693.
- 27 of the patents on this record were granted since Aug 23, 2026
- 46 terms have ended since Aug 23, 2026
- Nov 20 US 7,714,098 Mono-, Oligo- and Polythieno [3,2-b]thiophenes · term ended
- Nov 9 US 7,582,227 Optical Film Inside a Liquid Crystal Display · term ended
- Nov 3 US 7,781,672 Photovoltaic Module Architecture · term ended
- Nov 1 US 7,829,781 Photovoltaic Module Architecture · term ended
- Oct 30 US 10,115,932 Method of Designing Electroluminescent Device, Electroluminescent Device Manufactured with the Design Method, and Method of Manufacturing Electroluminescent Device with the Design Method · lapsed on the fee record
- Oct 28 US 7,829,658 Mono-,oligo- and Polymers of Thienothiazole · term ended
- Oct 23 US 10,109,800 Organic Electroluminescent Element, Display Device and Lighting Device · lapsed on the fee record
- Oct 16 US 10,103,347 Transparent Electrode, Method for Manufacturing Same, and Organic Electroluminescent Element · lapsed on the fee record
- Oct 16 US 10,100,253 Method of Preparing a Birefringent Polymer Film · lapsed on the fee record
- Oct 14 US 8,860,014 Organic Electroluminescent Member and Method for Producing Organic Electroluminescent Element · lapsed on the fee record
- Oct 14 US 8,859,547 Pyridazinone Derivatives · lapsed on the fee record
- Oct 11 US 7,781,670 Organic Photovoltaic Component with Encapsulation · term ended
- Oct 11 US 11,466,839 Wavelength Converting Component · lapsed on the fee record
- Oct 11 US 11,466,022 Materials for Organic Electroluminescent Devices · lapsed on the fee record
- Oct 11 US 11,466,021 Materials for Organic Electroluminescent Devices · lapsed on the fee record
What they patent
The largest of its 1,067 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Materials for Organic Light Emitting Devices | 6 in force | to Apr 2035 |
| TLR7/8 Antagonists and Uses Thereof | 5 in force | to Dec 2036 |
| Spirobifluorene Compounds for Organic Electroluminescent Devices | 5 in force | to Feb 2033 |
| Materials for Organic Electroluminescent Devices (2018) | 4 in force | to Apr 2037 |
| Imidazolonylquinolines and the Use Thereof as Atm Kinase Inhibitors | 4 in force | to Mar 2036 |
| Aptamers Specific for TLR-4 and Uses Thereof | 4 in force | to Jan 2036 |
| Liquid-Crystalline Medium (2015) | 4 in force | to Jun 2035 |
| Arylquinazolines | 4 in force | to May 2034 |
| ANTI-PD-L1 Antibodies and Uses Thereof | 4 in force | to Feb 2034 |
| Compounds and Organic Electronic Devices | 4 in force | to Jun 2033 |
| Compositions and Methods for the Production of Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity | 4 in force | to Jun 2032 |
| Materials for Organic Electroluminescent Devices (2012) | 4 in force | to Jan 2032 |
| Organic Electroluminescent Element, Display Device and Illuminating Device | 4 in force | to Feb 2029 |
| Liquid-Crystalline Medium (2018) | 3 in force | to Nov 2038 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,864,281 | Active Matrix Substrate and Display Unit Provided with It In force · High confidence | In force | High confidence | |
| US 7,491,482 | Photoactive Compounds In force · High confidence | In force | High confidence | |
| US 7,824,745 | Benzochromene Derivatives In force · High confidence | In force | High confidence | |
| US 7,947,382 | Electroluminescent Polymers and the Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 7,691,556 | Antireflective Compositions for Photoresists In force · Medium confidence | In force | Medium confidence | |
| US 7,699,680 | Method of Manufacturing an Organic Electroluminescent Element In force · High confidence | In force | High confidence | |
| US RE44,831 | Organic Electroluminescent Device, Display, and Illuminating Device In force · Low confidence | In force | Low confidence | |
| US RE45,216 | Organic Electroluminescent Device, Display, and Illuminating Device In force · Low confidence | In force | Low confidence | |
| US 7,799,916 | Process for the Preparation of 5-(4-[4-(5-Cyano-3-Indolyl)BUTYL]-1-Piperazinyl)BENZOFURAN-2-Carboxamide In force · High confidence | In force | High confidence | |
| US 8,188,248 | Nucleic Acids Encoding INTERLEUKIN-12P40 Variants with Improved Stability In force · High confidence | In force | High confidence |
Also on record, not counted in the 1,228: 368 patents in force now held by others · 1,650 patents ended · 555 applications pending · 1,224 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.